-
Characteristics of the included randomized controlled trials.
Characteristics of the included randomized controlled trials. -
From MSM model: Assessing two-way interactions between gender and smoking his...
From MSM model: Assessing two-way interactions between gender and smoking history for post-progression survival (N = 104/123). -
r37980778c78--1737f8ccad457ec4e6016bffda0c55c3
Comparison of outcomes of patients treated with and without spinal manual therapy. -
Demographic data
**P<0.01; SD, standard deviation; Max/Min, maximal/minimal.The number of participants did not differ between genders (Chi-square P>0.05). The dancer and pianist groups... -
Research and Development of Hepatitis B Drugs: An Analysis Based on Technolog...
Despite the existence of available therapies, the Hepatitis B virus infection continues to be one of the most serious threats to human health, especially in developing countries... -
Information of the main technology clusters in the patent citation network<su...
Information of the main technology clusters in the patent citation networka. -
Clinical features of 17 patients with HBV reactivation after radiotherapy.
Clinical features of 17 patients with HBV reactivation after radiotherapy. -
Broad perceptions of group and individual components of schema therapy.
Broad perceptions of group and individual components of schema therapy. -
Validity of Danish Breast Cancer Group (DBCG) registry data used in the predi...
Background: Validation studies of the Danish Breast Cancer Group (DBCG) registry show good agreement with medical records for adjuvant treatment data, but inconsistent... -
Median lag times between onset of symptoms and diagnosis in CD and UC.
Median lag times between onset of symptoms and diagnosis in CD and UC. -
Baseline characteristics of study participants at completion of Cryptococcal ...
Baseline characteristics of study participants at completion of Cryptococcal meningitis therapy. -
Probability of reaching each state of chronic hepatitis B.
Probability of reaching each state of chronic hepatitis B. -
r37980778c78--42d6c4c7018d7a39ebae4da110bb5f38
Performance of our system in finding the association between genomic anomaly and drug responses in PharmGKB dataset. -
Model parameters.
aSpecified with reference to Cook [30] and Waage et al. [36] using distributions defined in Biosecurity Australia [31]; b Derived from Sapoukhina et al. [37]; c ABS [6], Note...
